About ThermoGenesis
ThermoGenesis is a publicly listed company based in Rancho Cordova (United States) founded in 1986. Automated technologies for cell-based therapeutics and bio-processing are developed. The company has 41 employees. ThermoGenesis offers products and services including AXP® II System, BioArchive® System, PXP-1000 System, and 3D Bag Set. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Lab Automation. Its legal entity is ThermoGenesis Holdings, Inc. Its competitors include Multiply Labs, Celltrio and Aopia Biosciences; 2 of its 3 listed competitors have raised funding.
Company details
ThermoGenesis is developing automated technologies for cell-based therapeutics and bio-processing. It offers automated clinical biobanking, point-of-care applications for cell-based therapeutics, and automation for immuno-oncology. It offers AXP BioArchive which provides automated isolation, collection and storage of cord blood stem cells. Another product, MXP allows automated processing of autologous peripheral or bone marrow-derived stem cells. CXP BioArchive is the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology. The company operates as a wholly owned subsidiary of Cesca Therapeutics.
- Headquarters Rancho Cordova, United States
- Employees 41
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website thermogenesis.com
- Social LinkedIn X Facebook
- Legal Name Thermogenesis Holdings, Inc.
- Annual Revenue$9.45 M (USD)-9.9as on Dec 31, 2023
- Net Profit-$17.98 M (USD)-59.49as on Dec 31, 2023
- EBITDA-$5.43 M (USD)-3.04as on Dec 31, 2023
- Latest Funding Round$3M (USD), Post-IPO
Mar 2023
- Investors
- Employee Count41
Products & Services of ThermoGenesis
ThermoGenesis offers a comprehensive portfolio of products and services, including AXP® II System, BioArchive® System, PXP-1000 System, and 3D Bag Set.
System for obtaining bone marrow concentrates with minimal contamination.
Automated technology for preserving and protecting high-value cells.
Efficient separation of cord blood to retain stem cell viability.
Facilitates buffy coat transfer and cryoprotectant addition in a closed system.
Funding Insights of ThermoGenesis
- Total Rounds 5
- Last Round Post-IPO — $3M
- First Round $532,132
(May 2009)
- Investors Count 1
All 5 funding rounds of ThermoGenesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in ThermoGenesis
ThermoGenesis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for ThermoGenesis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ThermoGenesis
6 people are tracked at ThermoGenesis (1 in leadership, 3 in board & advisors, 2 in team); the tracked headcount is 41.
| Name | Role | Group |
|---|---|---|
Darrell Drysen | Vice President Of Operations, Sr. Project Manager | Leadership |
Joseph Jeff Thomis | Director | Board & advisors |
James Xu | Director | Board & advisors |
Biao Xi | Director | Board & advisors |
Jesus Ernesto Echevarria Barron | Sr. Project Engineer | Team |
Ryan Scally | Facilities Manager and Project Coordinator | Team |
Complete people profiles for ThermoGenesis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ThermoGenesis
ThermoGenesis is a publicly listed company on the OTC with ticker symbol THMO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Aug 2010
- Listed onNASDAQ: THMO
- Listed entityThermoGenesis Holdings, Inc.
- Exchange sectorHealth technology
- ISINUS88362L2097
- Share price$0.00 (+9900% on the day) · 2026-09-24
- Market capitalisation$1,584.75
- Volume (last session)252
Financials of ThermoGenesis
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2023 | $9.4M | -$18.0M | -$5.4M |
| 2022 | $10.5M | -$11.3M | -$5.3M |
| 2021 | $9.3M | -$11.4M | -$6.6M |
| 2020 | $9.7M | -$16.4M | -$8.1M |
Detailed financial statements for ThermoGenesis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of ThermoGenesis
4 dated milestones of ThermoGenesis across 37 years, from founding to its latest funding, stage changes and deals.
- Founded ThermoGenesis is founded.
- Funding First funding round of $532K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $3.0M.
Competitors of ThermoGenesis
ThermoGenesis has 3 listed competitors in our database, 2 of them funded. They include Multiply Labs, Celltrio and Aopia Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| multiplylabs.com | 2016 | San Francisco, United States | $41.32M | 34 | Precision medicines are manufactured via robotic systems for cell therapies. | |
| celltrio.com | 2018 | Santa Clara, United States | $15M | Developer of automated biobanking and cell culture systems | ||
| aopiabio.com | 2019 | Pleasanton, United States | Develops innovative tools for EV isolation and bioengineering in biotechnology field. |
Detailed competitors of ThermoGenesis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ThermoGenesis
Websites that share an audience with ThermoGenesis (thermogenesis.com).
Websites whose visitors overlap most with ThermoGenesis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| familycord.com | 100% | #7,770,185 | View details | ||
| molecularmatrix.com | 57% | 1.5K | #11,523,751 | View details | |
cichlidresearch.com | cichlidresearch.com | 56% | #14,672,194 | – | |
| nivagen.com | 56% | 8.5K | #2,347,838 | View details | |
| geminibio.com | 54% | 7.9K | #2,451,069 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for ThermoGenesis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as ThermoGenesis (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Thermogenesis
Complete news archive for ThermoGenesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ThermoGenesis
ThermoGenesis was founded in 1986 and raised its 1st funding round 23 years after it was founded.
ThermoGenesis is headquartered in Rancho Cordova, United States. It is registered at Rancho Cordova, California, United States.
ThermoGenesis has 41 employees.
Annual revenue of ThermoGenesis is $9.45M as on Dec 31, 2023.
ThermoGenesis is developing automated technologies for cell-based therapeutics and bio-processing. It offers automated clinical biobanking, point-of-care applications for cell-based therapeutics, and automation for immuno-oncology. It offers AXP BioArchive which provides automated isolation, collection and storage of cord blood stem cells. Another product, MXP allows automated processing of autologous peripheral or bone marrow-derived stem cells. CXP BioArchive is the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology. The company operates as a wholly owned subsidiary of Cesca Therapeutics.
ThermoGenesis's top competitors include Multiply Labs, Celltrio and Aopia Biosciences.
ThermoGenesis offers AXP® II System, BioArchive® System, PXP-1000 System, and 3D Bag Set.
Yes, ThermoGenesis is publicly traded on OTC under the ticker symbol THMO.
ThermoGenesis has 1 investor. Key investors include HHS.
ThermoGenesis operates through Thermogenesis Holdings, Inc..